KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Change in Receivables (2016 - 2025)

LifeMD's Change in Receivables history spans 14 years, with the latest figure at $459227.0 for Q4 2025.

  • For Q4 2025, Change in Receivables rose 162.48% year-over-year to $459227.0; the TTM value through Dec 2025 reached -$1.2 million, down 125.64%, while the annual FY2025 figure was -$1.2 million, 125.64% down from the prior year.
  • Change in Receivables reached $459227.0 in Q4 2025 per LFMD's latest filing, up from -$95817.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $4.8 million in Q3 2024 to a low of -$1.5 million in Q1 2025.
  • Average Change in Receivables over 5 years is $397734.8, with a median of $356301.5 recorded in 2021.
  • Peak YoY movement for Change in Receivables: surged 2962.51% in 2023, then tumbled 2644.03% in 2025.
  • A 5-year view of Change in Receivables shows it stood at -$986755.0 in 2021, then surged by 164.33% to $634825.0 in 2022, then skyrocketed by 35.26% to $858668.0 in 2023, then tumbled by 185.6% to -$734988.0 in 2024, then skyrocketed by 162.48% to $459227.0 in 2025.
  • Per Business Quant, the three most recent readings for LFMD's Change in Receivables are $459227.0 (Q4 2025), -$95817.0 (Q3 2025), and -$6840.0 (Q2 2025).